Clinical Trial Update: Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan, capecitabine, and bevacizumab for metastatic colorectal cancer as salvage therapy; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Capecitabine (Xeloda) (Capecitabine)
• Irinotecan (Camptosar) (Irinotecan)

Snippet

Sponsor: University Hospital of Crete | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED